Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use'

Loading news article.

Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use' | WAPE

Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use'

Article summary

Related companies

Comments —